glp-1 legal team Law & Policy glp-1 diarrhea legal team in
Description
Mounjaro is the brand name for tirzepatide, a next-generation medication originally developed for type 2 diabetes
282,283 Similarly, tirzepatide decreased left ventricular mass and paracardiac adipose tissue in patients with obesity-associated heart failure, corresponding with a reduced risk of heart failure events
They work by mimicking a naturally occurring hormone called glucagon-like peptide-1, which plays several roles in metabolism
All studies were interventional, meaning they actively tested GLP-1 as a treatment intervention rather than simply observing existing conditions
The statements about Replenza have not been evaluated by the FDA, and the product is not intended to diagnose, treat, cure, or prevent any disease
